Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)
China flag China · Delayed Price · Currency is CNY
7.59
-0.10 (-1.30%)
Nov 6, 2026, 11:55 AM CST

SHE:002873 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
9.649.1152.3280.87111.52100.61
Depreciation & Amortization
37.0137.6837.3823.3425.4522.81
Other Amortization
7.476.81.611.471.282.69
Loss (Gain) From Sale of Assets
0.780.78-18.9-0.020.1
Asset Writedown & Restructuring Costs
0.160.160.710.070.120.37
Loss (Gain) From Sale of Investments
0.020.02-0.020.720.4-
Provision & Write-off of Bad Debts
-1.38-1.382.61-0.270.521.73
Other Operating Activities
81.0221.4223.3316.1115.2317.52
Change in Accounts Receivable
49.9549.95-38.037-20.18-8.45
Change in Inventory
-30.23-30.2335.8-1.2-66.75-40.35
Change in Accounts Payable
-11.11-11.11-10-52.081.7925.94
Operating Cash Flow
143.8683.7388.1377.7875.82124.3
Operating Cash Flow Growth
-3.73%-4.99%13.30%2.59%-39.00%-29.28%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-65.62-51.59-61.45-101.7-129.2-105.69
Sale of Property, Plant & Equipment
2.392.1415.0850.030.08
Cash Acquisitions
-7.91-2.99----
Investment in Securities
0.07-400050-112
Other Investing Activities
0.020.01----
Investing Cash Flow
-71.05-92.43-46.37-96.7-79.17-217.61

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-532.75680506347273
Total Debt Issued
386.18532.75680506347273
Long-Term Debt Repaid
--421.63-577.29-404-278-418.63
Total Debt Repaid
-427.86-421.63-577.29-404-278-418.63
Net Debt Issued (Repaid)
-41.67111.12102.7110269-145.63
Issuance of Common Stock
24.56----27.81
Repurchase of Common Stock
-5.44-5.44-129.48-2.99-3.1-15.02
Common Dividends Paid
-25.51-41.42-35.06-42.53-34.35-30.33
Other Financing Activities
0.52-----1.12
Financing Cash Flow
-47.5464.25-61.8356.4831.54-164.3

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
---0--
Net Cash Flow
25.2755.56-20.0737.5728.19-257.61

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
78.2432.1426.68-23.92-53.3818.61
Free Cash Flow Growth
-27.55%20.48%----82.71%
Free Cash Flow Margin
11.27%4.29%3.11%-2.51%-4.91%1.92%
Free Cash Flow Per Share
0.340.140.12-0.10-0.220.08
Levered Free Cash Flow
89.125.56-6.5-31.37-97.92-17.28
Unlevered Free Cash Flow
92.3816.664.48-23.99-91.24-6.9

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
76.886.3379.8697.63117.84112
Change in Working Capital
9.159.15-10.9-44.54-78.71-21.52